Full-Service Global Support for COVID-19 Studies

  • Post author:
  • Post category:

Our broad expertise, end-to-end services and ability to begin immediate collaboration with government, commercial and academic partners in more than 60 countries make us uniquely positioned to support the COVID-19 response. We address emerging pandemics, epidemics and outbreaks with expertise that supports health and research efforts globally. We are experienced in addressing the complex aspects of infectious diseases — from infection prevention and control to clinical research on diagnostics, vaccines and treatment.

Continue ReadingFull-Service Global Support for COVID-19 Studies

About FHI Clinical

  • Post author:
  • Post category:

FHI Clinical goes where our expertise is needed. Whether it requires working from a state-of-the-art facility or in a low-tech, rural setting, we provide services tailored to meet your study needs, from protocol design and site assessments to trial planning, implementation and management.

Continue ReadingAbout FHI Clinical

Participant Recruitment and Retention Can Require Agile Solutions

  • Post author:
  • Post category:

Participant recruitment and retention can be challenged by many factors such as a long follow-up period, lack of accessible sites and unclear expectations. Our team helps develop and implement agile solutions to overcome these difficulties, as described in this video for multiple studies including a global, multi-site oncology trial.

Continue ReadingParticipant Recruitment and Retention Can Require Agile Solutions

Following the Epidemiology in Infectious Disease Trials: A COVID-19 Case Study

  • Post author:
  • Post category:

With infectious disease outbreaks, expanding immunity from previous infection and vaccination efforts can change where the outbreak is occurring. In this video, Loice Magaria, Clinical Research Project Manager at FHI Clinical discusses strategies implemented to address changing epidemiology in a study investigating COVID-19 treatments.

Continue ReadingFollowing the Epidemiology in Infectious Disease Trials: A COVID-19 Case Study